Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme

Annals of the Rheumatic Diseases

Volumn 73, Issue 7, 2014, Pages 1350-1355

  Fernandez Espartero C ^a   De Miguel, E ^b   Loza, E ^c   Tomero, E ^d   Gobbo, M ^e   Descalzo, M A ^e   Collantes Estevez E ^f   Mulero, J ^g   Munoz Fernandez S ^h   Zarco, P ⁱ   Carmona, L ^c,j  

^a HOSPITAL DE MÓSTOLES   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Institute for Health   (Spain)

^d Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^e UNIDAD DE INVESTIGACIÓN   (Spain)

^f UNIVERSITY OF CÓRDOBA   (Spain)

^g HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^h HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^j CAMILO JOSÉ CELA UNIVERSITY   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; CONVERGENT VALIDITY; DISCRIMINANT VALIDITY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH PROGRAM; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PHYSICIAN GLOBAL SCORE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCORING SYSTEM; SPONDYLARTHRITIS; STANDARDIZATION; VALIDATION STUDY;

DISEASE ACTIVITY; OUTCOMES RESEARCH; SPONDYLOARTHRITIS;

ADULT; BACK PAIN; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TIME FACTORS;

EID: 84902258785     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202976     Document Type: Article

References (11)

1. Boers M, Brooks P, Strand V, et al. The OMERACT Filter for outcome measures in rheumatology. J R Heumatol 1998;25:198-9.
2. van der Heijde D, Lie D, Kvein IT, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:1811-18.
3. Eder L, Chandran V, Shen H, et al. Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Ann Rheum Dis 2010;69:2160-64.
4. Muñoz-Fernández S, Carmona L, Collantes E, et al. A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: The Esperanza Program. Ann Rheum Dis 2011;70:827-30.
5. Fernández Carbadillo C. Diagnóstico precoz de las espondiloartropatías en España: el programa ESPeranza. Reumatol Clin 2010;6:6-10.
6. Machado P, Landewé R, Lie E, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011;70:47-53.
7. Rudwaleit M, Landewé R, van der Heijde D, et al. The Development of Assessment of SpondyloArthritis international Society (ASAS) Classification Criteria for Axial Spondyloarthritis (Part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770-6.
8. Rudwaleit M, van der Heijde D, Landewé R, et al. The Development of Assessment of SpondyloArthritis international Society (ASAS) Classification Criteria for Axial Spondyloarthritis (Part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
9. Lukas C, Landewé R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18-24.
10. Pedersen SJ, Sørensen IJ, Hermann KG, et al. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors. Ann Rheum Dis 2010;69:1065-71.
11. Pedersen SJ, Sørensen IJ, Garnero P, et al. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors. Ann Rheum Dis 2011;70:1375-81.